Mark Vineis appointed as the new Country President of Novartis Canada
MONTREAL, Dec. 5, 2023 /CNW/ - Novartis Canada announces that Mark Vineis has been appointed to the role of Country President, effective as of January 1, 2024.
- MONTREAL, Dec. 5, 2023 /CNW/ - Novartis Canada announces that Mark Vineis has been appointed to the role of Country President, effective as of January 1, 2024.
- As Country President, Mark will take overall leadership of the Novartis strategy within Canada, focused on developing innovative healthcare solutions to address the evolving needs of patients in four primary therapeutic areas: Cardiovascular and metabolic diseases, Oncology, Immunology and Neuroscience.
- "I am excited and honoured to take on this role within Novartis, and I am eager to begin working with stakeholders from across the Canadian healthcare system to improve the health of millions of Canadians," said Mark Vineis, Country President, Novartis Canada.
- Mark succeeds former Country President Andrea Marazzi, who moved to a new position within Novartis in September 2023.